Cargando…
Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer
Distant metastasis is a major cause of increased mortality in breast cancer patients, but the mechanisms underlying breast cancer metastasis remain poorly understood. In this study, we aimed to identify a metastasis-related gene (MRG) signature for predicting progression in breast cancer. By screeni...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208079/ https://www.ncbi.nlm.nih.gov/pubmed/37304008 http://dx.doi.org/10.32604/or.2022.026616 |
_version_ | 1785046595839983616 |
---|---|
author | XIAO, GUODONG CHENG, FENG YUAN, JING LU, WEIPING WANG, PEILI FAN, HUIJIE |
author_facet | XIAO, GUODONG CHENG, FENG YUAN, JING LU, WEIPING WANG, PEILI FAN, HUIJIE |
author_sort | XIAO, GUODONG |
collection | PubMed |
description | Distant metastasis is a major cause of increased mortality in breast cancer patients, but the mechanisms underlying breast cancer metastasis remain poorly understood. In this study, we aimed to identify a metastasis-related gene (MRG) signature for predicting progression in breast cancer. By screening using three regression analysis methods, a 9-gene signature (NOTCH1, PTP4A3, MMP13, MACC1, EZR, NEDD9, PIK3CA, F2RL1 and CCR7) was constructed based on an MRG set in the BRCA cohort from TCGA. This signature exhibited strong robustness, and its generalizability was verified in the Metabric and GEO cohorts. Of the nine MRGs, EZR is an oncogenic gene with a well-documented role in cell adhesion and cell migration, but it has rarely been investigated in breast cancer. Based on a search of different databases, EZR was found to be significantly more highly expressed in both breast cancer cells and breast cancer tissue. EZR knockdown significantly inhibited cell proliferation, invasion, chemoresistance and EMT in breast cancer. Mechanistically, RhoA activation assays confirmed that EZR knockdown inhibited the activity of RhoA, Rac1 and Cdc42. In summary, we identified a nine-MRG signature that can be used as an efficient prognostic indicator for breast cancer patients, and owing to its involvement in regulating breast cancer metastasis, EZR might serve as a therapeutic target. |
format | Online Article Text |
id | pubmed-10208079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Tech Science Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102080792023-06-10 Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer XIAO, GUODONG CHENG, FENG YUAN, JING LU, WEIPING WANG, PEILI FAN, HUIJIE Oncol Res Article Distant metastasis is a major cause of increased mortality in breast cancer patients, but the mechanisms underlying breast cancer metastasis remain poorly understood. In this study, we aimed to identify a metastasis-related gene (MRG) signature for predicting progression in breast cancer. By screening using three regression analysis methods, a 9-gene signature (NOTCH1, PTP4A3, MMP13, MACC1, EZR, NEDD9, PIK3CA, F2RL1 and CCR7) was constructed based on an MRG set in the BRCA cohort from TCGA. This signature exhibited strong robustness, and its generalizability was verified in the Metabric and GEO cohorts. Of the nine MRGs, EZR is an oncogenic gene with a well-documented role in cell adhesion and cell migration, but it has rarely been investigated in breast cancer. Based on a search of different databases, EZR was found to be significantly more highly expressed in both breast cancer cells and breast cancer tissue. EZR knockdown significantly inhibited cell proliferation, invasion, chemoresistance and EMT in breast cancer. Mechanistically, RhoA activation assays confirmed that EZR knockdown inhibited the activity of RhoA, Rac1 and Cdc42. In summary, we identified a nine-MRG signature that can be used as an efficient prognostic indicator for breast cancer patients, and owing to its involvement in regulating breast cancer metastasis, EZR might serve as a therapeutic target. Tech Science Press 2022-12-06 /pmc/articles/PMC10208079/ /pubmed/37304008 http://dx.doi.org/10.32604/or.2022.026616 Text en © 2022 Xiao et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article XIAO, GUODONG CHENG, FENG YUAN, JING LU, WEIPING WANG, PEILI FAN, HUIJIE Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer |
title | Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer |
title_full | Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer |
title_fullStr | Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer |
title_full_unstemmed | Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer |
title_short | Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer |
title_sort | integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of ezr in breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208079/ https://www.ncbi.nlm.nih.gov/pubmed/37304008 http://dx.doi.org/10.32604/or.2022.026616 |
work_keys_str_mv | AT xiaoguodong integrativemultiomicsanalysisidentifiesametastasisrelatedgenesignatureandthepotentialoncogenicroleofezrinbreastcancer AT chengfeng integrativemultiomicsanalysisidentifiesametastasisrelatedgenesignatureandthepotentialoncogenicroleofezrinbreastcancer AT yuanjing integrativemultiomicsanalysisidentifiesametastasisrelatedgenesignatureandthepotentialoncogenicroleofezrinbreastcancer AT luweiping integrativemultiomicsanalysisidentifiesametastasisrelatedgenesignatureandthepotentialoncogenicroleofezrinbreastcancer AT wangpeili integrativemultiomicsanalysisidentifiesametastasisrelatedgenesignatureandthepotentialoncogenicroleofezrinbreastcancer AT fanhuijie integrativemultiomicsanalysisidentifiesametastasisrelatedgenesignatureandthepotentialoncogenicroleofezrinbreastcancer |